You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 18, October 10, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Lipids and Lipid Disorders
 •Aging/ Geriatrics
 •Alert me on articles by topic

Lipoprotein Peroxidation and Mobility Limitation

Results From the Health, Aging, and Body Composition Study

Matteo Cesari, MD, PhD; Stephen B. Kritchevsky, PhD; Barbara J. Nicklas, PhD; Brenda W. H. J. Penninx, PhD; Paul Holvoet, MD; Pauline Koh-Banerjee, MD; Steven R. Cummings, MD; Tamara B. Harris, MD; Anne B. Newman, PhD; Marco Pahor, MD

Arch Intern Med. 2005;165:2148-2154.

Background  Oxidative damage plays an important role in leading to major health-related events. The aim of this study was to assess the predictive value of a lipoprotein peroxidation marker, oxidized low-density lipoprotein (oxLDL) for incident mobility limitation (ML).

Methods  Data are from 2985 well-functioning elders enrolled in the Health ABC study (median follow-up, 4.1 years). All oxLDL levels were measured at the baseline assessment. The oxLDL/LDL cholesterol (LDL-C) ratio (log value) was used as a measure of lipoprotein peroxidation. Mobility limitation was defined by 2 consecutive semiannual reports of any difficulty either walking 1/4 mile or climbing up 10 steps without resting. Severe ML was defined by 2 consecutive reports of great difficulty or inability to do the same tasks. Cox proportional hazards models were performed to assess hazard ratios (HRs) and 95% confidence intervals (CIs).

Results  The mean (SD) age of the sample was 74.2 (2.9) years. After adjustment for potential confounders (sociodemographic factors, smoking, physical activity, body mass index, clinical conditions, biological markers, and medications), the relationship between the oxLDL/LDL-C ratio and disability events was statistically significant (per log-unit difference in the oxLDL/LDL-C ratio) (for ML: HR, 1.22; 95% CI, 1.06-1.41; for severe ML: HR, 1.43; 95% CI, 1.15-1.79). Consistent results were found when interleukin 6 level was included as a covariate in the adjusted models (ML: HR, 1.13; 95% CI, 0.98-1.31; severe ML: HR, 1.31; 95% CI, 1.05-1.64). No significant sex, race, interleukin 6 level, or clinical conditions interaction was found with the oxLDL/LDL-C ratio and mobility disability.

Conclusions  Lipoprotein peroxidation predicts the onset of ML in older persons. The oxLDL predictive value for ML is partly explained by interleukin 6 levels.


Author Affiliations: Department of Aging and Geriatric Research, College of Medicine, Institute on Aging, University of Florida, Gainesville (Drs Cesari and Pahor); Sticht Center on Aging and Rehabilitation, Wake Forest University School of Medicine, Winston Salem, NC (Drs Cesari, Kritchevsky, Nicklas, and Pahor); Department of Psychiatry, Vrije Universiteit, Amsterdam, the Netherlands (Dr Penninx); Center for Experimental Surgery and Anesthesiology, University of Leuven, Leuven, Belgium (Dr Holvoet); Department of Preventive Medicine, University of Tennessee, Memphis (Dr Koh-Banerjee); University of California, San Francisco (Dr Cummings); National Institute on Aging, National Institutes of Health, Bethesda, Md (Dr Harris); and Department of Medicine, University of Pittsburgh, Pittsburgh, Pa (Dr Newman).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Serum Micronutrient Concentrations and Decline in Physical Function Among Older Persons
Bartali et al.
JAMA 2008;299:308-315.
ABSTRACT | FULL TEXT  

Effect of a Traditional Mediterranean Diet on Lipoprotein Oxidation: A Randomized Controlled Trial
Fito et al.
Arch Intern Med 2007;167:1195-1203.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.